{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:46:47Z","timestamp":1795200407171,"version":"4.10.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Plasmid-borne colistin resistance mediated by\n                    <jats:italic>mcr-1<\/jats:italic>\n                    may contribute to the dissemination of pan-resistant Gram-negative bacteria. Here, we show that\n                    <jats:italic>mcr-1<\/jats:italic>\n                    confers resistance to colistin-induced lysis and bacterial cell death, but provides minimal protection from the ability of colistin to disrupt the Gram-negative outer membrane. Indeed, for colistin-resistant strains of Enterobacteriaceae expressing plasmid-borne\n                    <jats:italic>mcr-1<\/jats:italic>\n                    , clinically relevant concentrations of colistin potentiate the action of antibiotics that, by themselves, are not active against Gram-negative bacteria. The result is that several antibiotics, in combination with colistin, display growth-inhibition at levels below their corresponding clinical breakpoints. Furthermore, colistin and clarithromycin combination therapy displays efficacy against\n                    <jats:italic>mcr-1<\/jats:italic>\n                    -positive\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    in murine thigh and bacteremia infection models at clinically relevant doses. Altogether, these data suggest that the use of colistin in combination with antibiotics that are typically active against Gram-positive bacteria poses a viable therapeutic alternative for highly drug-resistant Gram-negative pathogens expressing\n                    <jats:italic>mcr-1<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-02875-z","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T10:40:26Z","timestamp":1516876826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":286,"title":["Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics"],"prefix":"10.1038","volume":"9","author":[{"given":"Craig R.","family":"MacNair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.","family":"Carfrae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline A.","family":"Fiebig-Comyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Mulvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"key":"2875_CR1","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1021\/bi00587a024","volume":"18","author":"M Schindler","year":"1979","unstructured":"Schindler, M. & Osborn, M. J. Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry 18, 4425\u20134430 (1979).","journal-title":"Biochemistry"},{"key":"2875_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/br.20.1.14-27.1956","volume":"20","author":"BA Newton","year":"1956","unstructured":"Newton, B. A. The properties and mode of action of the polymyxins. Bacteriol. Rev. 20, 14\u201327 (1956).","journal-title":"Bacteriol. Rev."},{"key":"2875_CR3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ijantimicag.2016.11.029","volume":"49","author":"K Jeannot","year":"2017","unstructured":"Jeannot, K., Bolard, A. & Pl\u00e9siat, P. Resistance to polymyxins in Gram-negative organisms. Int. J. Antimicrob. Agents 49, 526\u2013535 (2017).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2875_CR4","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1128\/AAC.01480-13","volume":"57","author":"A Cannatelli","year":"2013","unstructured":"Cannatelli, A. et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ\/PhoP mgrB regulator. Antimicrob. Agents Chemother. 57, 5521\u20135526 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2875_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.tim.2008.03.007","volume":"16","author":"JS Gunn","year":"2008","unstructured":"Gunn, J. S. The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol. 16, 284\u2013290 (2008).","journal-title":"Trends Microbiol."},{"key":"2875_CR6","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1128\/JCM.01017-15","volume":"53","author":"T Giani","year":"2015","unstructured":"Giani, T. et al. Large nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrb deletion mutant. J. Clin. Microbiol. 53, 3341\u20133344 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"2875_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"YYY Liu","year":"2015","unstructured":"Liu, Y.-Y. Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16, 161\u2013168 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"2875_CR8","doi-asserted-by":"publisher","first-page":"e00177","DOI":"10.1128\/mBio.00177-16","volume":"7","author":"H Ye","year":"2016","unstructured":"Ye, H. et al. Diversified mcr-1-harbouring plasmid reservoirs confer resistance to colistin in human gut microbiota. MBio 7, e00177 (2016).","journal-title":"MBio"},{"key":"2875_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1473-3099(16)00009-8","volume":"16","author":"L Falgenhauer","year":"2016","unstructured":"Falgenhauer, L. et al. Colistin resistance gene mcr-1 in extended-spectrum \u03b2-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany. Lancet Infect. Dis. 16, 282\u2013283 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"2875_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/jac\/41.4.494","volume":"41","author":"GM Hogg","year":"1998","unstructured":"Hogg, G. M., Barr, J. G. & Webb, C. H. In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii. J. Antimicrob. Chemother. 41, 494\u2013495 (1998).","journal-title":"J. Antimicrob. Chemother."},{"key":"2875_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0732-8893(01)00258-9","volume":"40","author":"EJ Giamarellos-Bourboulis","year":"2001","unstructured":"Giamarellos-Bourboulis, E. J., Xirouchaki, E. & Giamarellou, H. Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis. 40, 117\u2013120 (2001).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"2875_CR12","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1128\/AAC.01230-13","volume":"57","author":"O Zusman","year":"2013","unstructured":"Zusman, O. et al. Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob. Agents Chemother. 57, 5104\u20135111 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2875_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ijantimicag.2005.10.012","volume":"27","author":"F Timurkaynak","year":"2006","unstructured":"Timurkaynak, F. et al. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int. J. Antimicrob. Agents 27, 224\u2013228 (2006).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2875_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jac\/29.1.19","volume":"29","author":"I Chopra","year":"1992","unstructured":"Chopra, I. & Hacker, K. Uptake of minocycline by Escherichia coli. J. Antimicrob. Chemother. 29, 19\u201325 (1992).","journal-title":"J. Antimicrob. Chemother."},{"key":"2875_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijantimicag.2010.10.031","volume":"37","author":"S Pournaras","year":"2011","unstructured":"Pournaras, S. et al. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. Int. J. Antimicrob. Agents 37, 244\u2013247 (2011).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2875_CR16","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1128\/AAC.00922-10","volume":"54","author":"NC Gordon","year":"2010","unstructured":"Gordon, N. C., Png, K. & Wareham, D. W. Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob. Agents Chemother. 54, 5316\u20135322 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2875_CR17","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1099\/00221287-147-10-2769","volume":"147","author":"A Rumijowska-Galewicz","year":"2001","unstructured":"Rumijowska-Galewicz, A., Lisowska, K., Korycka-Macha\u0142a, M., Sedlaczek, L. & Zi\u00f3\u0142kowski, A. Polycations increase the permeability of Mycobacterium vaccae cell envelopes to hydrophobic compounds. Microbiology 147, 2769\u20132781 (2001).","journal-title":"Microbiology"},{"key":"2875_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijantimicag.2017.01.005","volume":"49","author":"M Klinger-Strobel","year":"2017","unstructured":"Klinger-Strobel, M., Stein, C., Forstner, C., Makarewicz, O. & Pletz, M. W. Effects of colistin on biofilm matrices of Escherichia coli and Staphylococcus aureus. Int. J. Antimicrob. Agents 49, 472\u2013479 (2017).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2875_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/ja.2016.77","volume":"70","author":"TB Lima","year":"2016","unstructured":"Lima, T. B. et al. Antibiotic combinations for controlling colistin-resistant Enterobacter cloacae. J. Antibiot. (Tokyo). 70, 122\u2013129 (2016).","journal-title":"J. Antibiot. (Tokyo)."},{"key":"2875_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1556\/AMicr.60.2013.2.10","volume":"60","author":"B K\u00e1d\u00e1r","year":"2013","unstructured":"K\u00e1d\u00e1r, B. et al. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae. Acta Microbiol. Immunol. Hung. 60, 201\u2013209 (2013).","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"2875_CR21","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1128\/AAC.05996-11","volume":"56","author":"C Vidaillac","year":"2012","unstructured":"Vidaillac, C., Benichou, L. & Duval, R. E. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. Antimicrob. Agents Chemother. 56, 4856\u20134861 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2875_CR22","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1073\/pnas.0408238102","volume":"102","author":"I Zwir","year":"2005","unstructured":"Zwir, I. et al. Dissecting the PhoP regulatory network of Escherichia coli and Salmonella enterica. Proc. Natl Acad. Sci. USA 102, 2862\u20132867 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2875_CR23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1128\/AAC.04037-14","volume":"59","author":"MS Wright","year":"2015","unstructured":"Wright, M. S. et al. Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob. Agents Chemother. 59, 536\u2013543 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2875_CR24","doi-asserted-by":"publisher","first-page":"676.e1","DOI":"10.1016\/j.cmi.2017.03.015","volume":"23","author":"J Dobias","year":"2017","unstructured":"Dobias, J., Poirel, L. & Nordmann, P. Cross-resistance to human cationic antimicrobial peptides and to polymyxins mediated by the plasmid-encoded MCR-1? Clin. Microbiol. Infect. \u200b23, 676.e1\u2013676.e5 (2017).","journal-title":"Clin. Microbiol. Infect."},{"key":"2875_CR25","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nmicrobiol.2017.28","volume":"2","author":"JM Stokes","year":"2017","unstructured":"Stokes, J. M. et al. Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance. Nat. Microbiol. 2, 17028 (2017).","journal-title":"Nat. Microbiol."},{"key":"2875_CR26","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/jac\/dkx038","volume":"72","author":"YF Zhou","year":"2017","unstructured":"Zhou, Y. -F. et al. Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1. J. Antimicrob. Chemother. 72, 1723\u20131730 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"2875_CR27","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/AAC.01733-10","volume":"55","author":"SM Garonzik","year":"2011","unstructured":"Garonzik, S. M. et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob. Agents Chemother. 55, 3284\u20133294 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2875_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1517\/17425255.2011.541439","volume":"7","author":"AS Michalopoulos","year":"2011","unstructured":"Michalopoulos, A. S., Karatza, D. C. & Gregorakos, L. Pharmacokinetic evaluation of colistin sodium. Expert Opin. Drug. Metab. Toxicol. 7, 245\u2013255 (2011).","journal-title":"Expert Opin. Drug. Metab. Toxicol."},{"key":"2875_CR29","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1128\/AAC.01361-08","volume":"53","author":"D Plachouras","year":"2009","unstructured":"Plachouras, D. et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob. Agents Chemother. 53, 3430\u20133436 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2875_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1128\/AAC.30.1.42","volume":"30","author":"GL Drusano","year":"1986","unstructured":"Drusano, G. L. et al. Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination. Antimicrob. Agents Chemother. 30, 42\u201345 (1986).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2875_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijantimicag.2016.04.011","volume":"48","author":"S Esposito","year":"2016","unstructured":"Esposito, S. et al. Hot topics in the diagnosis and management of skin and soft-tissue infections. Int. J. Antimicrob. Agents 48, 19\u201326 (2016).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2875_CR32","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1016\/j.bmc.2016.09.053","volume":"24","author":"CR MacNair","year":"2016","unstructured":"MacNair, C. R. et al. A cell-based approach to characterize antimicrobial compounds through kinetic dose response. Bioorg. Med. Chem. 24, 6315\u20136319 (2016).","journal-title":"Bioorg. Med. Chem."},{"key":"2875_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrd3013","volume":"9","author":"DA Rasko","year":"2010","unstructured":"Rasko, D. A. & Sperandio, V. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 9, 117\u2013128 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2875_CR34","unstructured":"Package insert: Colistimethate for injection (Coly-mycin M Parenteral). JHP Pharmaceuticals, LLC, Rochester, MI 48307. Revised February 2011."},{"key":"2875_CR35","unstructured":"Package insert: BIAXIN\u00ae Filmtab\u00ae (clarithromycin tablets, USP). Abbott Pharmaceuticals PR Ltd, Barceloneta, PR 00617 (2012)."},{"key":"2875_CR36","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.peptides.2003.08.023","volume":"24","author":"JPS Powers","year":"2003","unstructured":"Powers, J. P. S. & Hancock, R. E. W. The relationship between peptide structure and antibacterial activity. Peptides 24, 1681\u20131691 (2003).","journal-title":"Peptides"},{"key":"2875_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1574-6968.1981.tb06989.x","volume":"11","author":"M Vaara","year":"1981","unstructured":"Vaara, M. Effect of ionic strength on polymyxin resistance of pmrA mutants of Salmonella. Fems Microbiol. Lett. 11, 321\u2013325 (1981).","journal-title":"Fems Microbiol. Lett."},{"key":"2875_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.abb.2017.03.008","volume":"620","author":"J Salazar","year":"2017","unstructured":"Salazar, J., Alarc\u00f3n, M., Huerta, J., Navarro, B. & Aguayo, D. Phosphoethanolamine addition to the Heptose I of the Lipopolysaccharide modifies the inner core structure and has an impact on the binding of Polymyxin B to the Escherichia coli outer membrane. Arch. Biochem. Biophys. 620, 28\u201334 (2017).","journal-title":"Arch. Biochem. Biophys."},{"key":"2875_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","volume":"67","author":"H Nikaido","year":"2003","unstructured":"Nikaido, H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67, 593\u2013656 (2003).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"2875_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ab.2010.10.033","volume":"409","author":"RL Soon","year":"2011","unstructured":"Soon, R. L. et al. Design, synthesis, and evaluation of a new fluorescent probe for measuring polymyxin-lipopolysaccharide binding interactions. Anal. Biochem. 409, 273\u2013283 (2011).","journal-title":"Anal. Biochem."},{"key":"2875_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/1753425913493337","volume":"20","author":"T Velkov","year":"2014","unstructured":"Velkov, T. et al. Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae. Innate Immun. 20, 350\u2013363 (2014).","journal-title":"Innate Immun."},{"key":"2875_CR42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/303526a0","volume":"303","author":"M Vaara","year":"1983","unstructured":"Vaara, M. & Vaara, T. Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature 303, 526\u2013528 (1983).","journal-title":"Nature"},{"key":"2875_CR43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","volume":"43","author":"RE Hancock","year":"1999","unstructured":"Hancock, R. E. & Chapple, D. S. Peptide antibiotics. Antimicrob. Agents Chemother. 43, 1317\u20131323 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2875_CR44","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1021\/jm900999h","volume":"53","author":"T Velkov","year":"2010","unstructured":"Velkov, T., Thompson, P. E., Nation, R. L. & Li, J. Structure-activity relationships of polymyxin antibiotics. J. Med. Chem. 53, 1898\u20131916 (2010).","journal-title":"J. Med. Chem."},{"key":"2875_CR45","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1128\/JB.187.15.5387-5396.2005","volume":"187","author":"YL Tzeng","year":"2005","unstructured":"Tzeng, Y. L. et al. Cationic antimicrobial peptide resistance in Neisseria meningitidis. J. Bacteriol. 187, 5387\u20135396 (2005).","journal-title":"J. Bacteriol."},{"key":"2875_CR46","doi-asserted-by":"publisher","first-page":"2006.0008","DOI":"10.1038\/msb4100050","volume":"2","author":"T Baba","year":"2006","unstructured":"Baba, T. et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2, 2006.0008 (2006).","journal-title":"Mol. Syst. Biol."},{"key":"2875_CR47","unstructured":"CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard Tenth Edition. CLSI document M07-A10 (2015)."},{"key":"2875_CR48","doi-asserted-by":"crossref","unstructured":"Jenkins, S. G. & Schuetz, A. N. Current concepts in laboratory testing to guide antimicrobial therapy. Mayo Clinic Proceedings 87, 290\u2013308 (2012).","DOI":"10.1016\/j.mayocp.2012.01.007"},{"key":"2875_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1365-2672.2000.00971.x","volume":"88","author":"IM Helander","year":"2000","unstructured":"Helander, I. M. & Mattila-Sandholm, T. Fluorometric assessment of Gram-negative bacterial permeabilization. J. Appl. Microbiol. 88, 213\u2013219 (2000).","journal-title":"J. Appl. Microbiol."},{"key":"2875_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep15963","volume":"5","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. High specific selectivity and membrane-active mechanism of the synthetic centrosymmetric \u03b1-helical peptides with Gly-Gly pairs. Sci. Rep. 5, 15963 (2015).","journal-title":"Sci. Rep."},{"key":"2875_CR51","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nature13445","volume":"510","author":"AM King","year":"2014","unstructured":"King, A. M. et al. Aspergillomarasmine A overcomes metallo-\u03b2-lactamase antibiotic resistance. Nature 510, 503\u2013506 (2014).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02875-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02875-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02875-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:56:17Z","timestamp":1671522977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02875-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["2875"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-02875-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]},"assertion":[{"value":"26 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"458"}}